RESEARCH PAPER
Influential factors and barriers to opt for the uptake of HIV testing among the adult population at HIV-care admission in an area in the DR Congo: What can we learn?
 
More details
Hide details
 
Submission date: 2017-03-09
 
 
Final revision date: 2017-07-06
 
 
Acceptance date: 2017-10-04
 
 
Publication date: 2017-12-05
 
 
HIV & AIDS Review 2017;16(4):220-225
 
KEYWORDS
TOPICS
ABSTRACT
Introduction: To reverse the trends of the acquired immune deficiency syn-drome (AIDS) epidemic, reinforcement of personal protection and antiretroviral treat-ment (ART) initiation at right time are needed. The aim of the study was, a decade af-ter expanding AIDS medical care, to explore facilitating factors or those contributing to uptake or delay of human immunodeficiency virus (HIV) testing among individuals who access voluntary counselling and testing (VCT) in an urban area of the Democratic Republic of Congo (DRC).
Material and methods: A cross-sectional survey carried out among individu-als attending three VCT centres in Kinshasa, DRC.
Results: A total of 388 individuals with mean age 42 (9.4) years were includ-ed. Among them 34% were married, and 96% were living at home. Morbid and social events were the most important reasons cited for uptake of HIV testing in urban are-as. Among the most common barriers of the HIV testing observed, stigma was the first reason significantly prevalent cited among man while fear to know the HIV status, ignorance of seropositivity concepts and the existence of VCT screening were prevalent among females.
Conclusions: Two main events influencing the uptake of HIV testing and commonly known barriers to this were cited. These results generate questions about a fringe of the population, and call for further research for improved prevention poli-cy.
 
REFERENCES (40)
1.
UNAIDS, AIDS by the numbers, world day of AIDS 2015. Available at: http://www.unaids.org/sites/de..._ the_numbers_2015_fr.pdf [Accessed: 3 March 2016].
 
2.
Gilles Pialoux et France Lert, Rapport nouvelles méthodes de prévention et réduction des risques dans les groupes à haut risque vis-à-vis du VIH et des IST, 2010. Available at: http://vih.org/20100112/nouvel... [Accessed: 16 December 2016].
 
3.
ONUSIDA, estimations VIH et SIDA en République démocratique du Congo, 2014. Available at: http://www.unaids.org/fr/regio... [Accessed: 15 November 2015].
 
4.
Rapport d’activité sur la riposte au VIH/SIDA en R.D. Congo, Programme National Multisectoriel de Lutte contre le Sida, 2012. Available at: http://www.unaids.org/sites/de... [Accessed: 15 November 2015].
 
5.
Kautako-Kiambi M, Aloni-Ntetani M, Pululu P, et al. Socio-demographic, biological and clinical profile of patients living with HIV during screening in a voluntary counselling and screening centre in a rural area of Mbanza-Ngungu, Democratic Republic of Congo, in 2006-2011. Bull Soc Pathol Exot 2013; 106: 180-183.
 
6.
Musafiri J, Mbayo PM, Bakaswa G, et al. HIV seroprevalence among tuberculous patients in Kisangani in the Democratic Republic of Congo. Santé Publique 2013; 25: 483-490.
 
7.
Hayward P. Highlights from the seventh IAS Conference. Lancet Infect Dis 2013; 13: 659.
 
8.
Tshingani K, Mukumbi H, Lubangi MM, et al. Comparative and evolutionary profile of people infected with HIV on antiretroviral therapy in Kinshasa, Democratic Republic of Congo. Pan Afr Med J 2014; 19: 388.
 
9.
OMS/ONUSIDA, Guide du conseil et du dépistage du VIH à l’initiative du soignant dans les établissements de santé, Mai 2007.
 
10.
Module 8: Prévention de l’infection à VIH dans: Prise en charge globale du VIH dans les pays à ressources limitées, Guide de formation à l’usage des paramédicaux par Bouchaud O, Tidiane Ndour C, édition doin, 2011. Available at: http://www.pathexo.fr/standard- 1600-1.html [Accessed: 10 October 2015].
 
11.
Jean K. Testing the “Test and Treat” HIV prevention strategy: the example of Ivory Cost, Santé publique et épidémiologie. Université de Versailles-Saint Quentin en Yvelines, 2013. Available at: https://inriav3-preprod.archiv... [Access­ed: 16 October 2015].
 
12.
Obermeyer CM, Bott S, Carrieri P, et al. HIV testing, treatment and prevention: generic tools for operational research. World Health Organization, Geneva 2009.
 
13.
Carrizosa CM, Blumberg EJ, Hovell MF, et al. Determinants and prevalence of late HIV testing in Tijuana, Mexico. AIDS Patient Care STDS 2010; 24: 333-340.
 
14.
Mukolo A, Villegas R, Aliyu M, et al. Predictors of Late Presentation for HIV Diagnosis: A Literature Review and Suggested Way Forward. AIDS Behav 2013; 17: 5-30.
 
15.
Fonner VA, Denison J, Kennedy CE, et al. Voluntary counseling and testing (VCT) for changing HIV-related risk behavior in developing countries. Cochrane Database Syst Rev 2012; 9: CD001224.
 
16.
Mulanga-Kabeya C, Nzilambi N, Edidi B, et al. Evidence of stable HIV seroprevalences in selected populations in the Democratic Republic of the Congo. AIDS 1998; 12: 905-910.
 
17.
Piot P, Quinn TC, Taelman H, et al. Acquired immunodeficiency syndrome in a heterosexual population in Zaire. Lancet 1984; 2: 65-69.
 
18.
Chadborn TR, Delpech VC, Sabin CA, et al. The late diagnosis and consequent short-term mortality of HIV-infected heterosexuals (England and Wales, 2000-2004). AIDS 2006; 20: 2371-2379.
 
19.
Harries J, Cooper D, Myer L, et al. Policy maker and health care provider perspectives on reproductive decision-making amongst HIV-infected individuals in South Africa. BMC Public Health 2007; 7: 282.
 
20.
Tshingani K, Schirvel C, Mukumbi H, et al. Vulnerability factors for malnutrition among people living with HIV under antiretroviral treatment in an outpatient clinic: Kinshasa, Democratic Republic of Congo. HIV AIDS Rev 2014; 13: 18-25.
 
21.
DRC, Epidemiological fact sheet on HIV and AIDS, UNAIDS. WHO, Geneva 2008.
 
22.
Bertrand JT, Brown LF, Kinzonzi M, et al. AIDS knowledge in three sites in Bas-Zaire. AIDS Educ Prev 1992; 4: 251-266.
 
23.
Ngatu NR, Hirota R, Eitoku M, et al. Perception of the risk of sexual transmission of HIV among Congolese and Japanese university students. Environ Health Prev Med 2012; 17: 139-146.
 
24.
Ryder RW, Batter V, Kaseka N, et al. Effect of HIV-1 infection on tuberculosis and fertility in a large workforce in Kinshasa, Democratic Republic of the Congo. AIDS Patient Care STDS 2000; 14: 297-304.
 
25.
Kim AA, Malele F, Kaiser R, et al. HIV infection among internally displaced women and women residing in river populations along the Congo River, Democratic Republic of Congo. AIDS Behav 2009; 13: 914-920.
 
26.
Rimoin AW, Hoff NA, Djoko CF, et al. HIV infection and risk factors among the armed forces personnel stationed in Kinshasa, Democratic Republic of Congo. Int J STD AIDS 2015; 26: 187-195.
 
27.
Kayembe PK, Mapatano MA, Busangu AF, et al. Determinants of consistent condom use among female commercial sex workers in the Democratic Republic of Congo: implications for interventions. Sex Transm Infect 2008; 84: 202-206.
 
28.
Weinhardt LS, Carey MP, Johnson BT, et al. Effects of HIV Counseling and Testing on Sexual Risk Behavior: A Meta-Analytic Review of Published Research, 1985-1997. Am J Public Health 1999; 89: 1397-1405.
 
29.
Mwandagalirwa K, Jackson EF, McClamroch K, et al. Local differences in human immunodeficiency virus prevalence: a comparison of social venue patrons, antenatal patients, and sexually transmitted infection patients in eastern kinshasa. Sex Transm Dis 2009; 36: 406-412.
 
30.
Zihindula G, Maharaj P. Risk of Sexual Violence: Perspectives and Experiences of Women in a Hospital in the Democratic Republic of Congo. J Community Health 2015; 40: 736-743.
 
31.
Lusey H, San Sebastian M, Christianson M, et al. Conflicting discourses of church youths on masculinity and sexuality in the context of HIV in Kinshasa, Democratic Republic of Congo. SAHARA J 2014; 11: 84-93.
 
32.
Vandepitte JM, Malele F, Kivuvu DM, et al. HIV and other sexually transmitted infections among female sex workers in Kinshasa, Democratic Republic of Congo, in 2002. Sex Transm Dis 2007; 34: 203-208.
 
33.
Girardi E, Sabin CA, Monforte AD. Late diagnosis of HIV infection: epidemiological features, consequences and strategies to encourage earlier testing. J Acquir Immune Defic Syndr 2007; 46 Suppl 1: S3-S8.
 
34.
Musheke M, Ntalasha H, Gari S, et al. A systematic review of qualitative findings on factors enabling and deterring uptake of HIV testing in Sub-Saharan Africa. BMC Public Health 2013; 13: 220.
 
35.
Steward WT, Bharat S, Ramakrishna J, et al. Stigma is associated with delays in seeking care among HIV-infected people in India. J Int Assoc Provid AIDS Care 2013; 12: 103-109.
 
36.
Meiberg AE, Bos AE, Onya HE, et al. Fear of stigmatization as barrier to voluntary HIV counseling and testing in South Africa. East Afr J Public Health 2008; 5: 49-54.
 
37.
Palmer AK, Cescon A, Chan K, et al.; CANOC Collaboration. Factors associated with late initiation of highly active antiretroviral therapy among young HIV-positive men and women aged 18 to 29 years in Canada. J Int Assoc Provid AIDS Care 2014; 13: 56-62.
 
38.
Maman S, Mbwambo J, Hogan NM, et al. Women’s barriers to HIV-1 testing and disclosure: Challenges for HIV-1 voluntary counselling and testing. AIDS Care 2001; 13: 595-603.
 
39.
Mabunda G. Voluntary counselling and testing: Knowledge and practices in a rural South African village. J Transcult Nurs 2006; 17: 23-29.
 
40.
Dodds C, Keogh P, Chime O, et al. Outsider status: Stigma and discrimination experienced by gay men and African people with HIV. Sigma Research, London 2004.
 
eISSN:1732-2707
ISSN:1730-1270
Journals System - logo
Scroll to top